Literature DB >> 8835875

Cardiomyopathy and other symptomatic heart diseases associated with HIV infection.

A Herskowitz1.   

Abstract

Approximately 14 million persons worldwide are estimated to be infected with HIV-1. As more effective therapies have produced longer survival times for HIV-infected patients, new complications of late-stage HIV infection including HIV-related heart disease have emerged. The most common and life-threatening cardiovascular complication of HIV infection is the development of primary heart muscle disease associated with severe global left ventricular dysfunction (also termed cardiomyopathy). Other less common forms of symptomatic heart disease in HIV-1-infected patients are pericardial effusion with cardiac tamponade, high-grade arrhythmia with sudden cardiac death, and systemic embolization caused by nonbacterial thrombotic endocarditis or infective carditis. The demographic and clinical characteristics of HIV-infected patients who develop cardiomyopathy as well as potential enhancing risk factors are as yet poorly characterized. This review briefly describes the various presentations and potential causes of symptomatic HIV-related heart disease and discusses the challenge facing clinicians who evaluate HIV-infected patients presenting with serious cardiac manifestations of their disease.

Entities:  

Mesh:

Year:  1996        PMID: 8835875     DOI: 10.1097/00001573-199605000-00013

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  5 in total

1.  Autonomic and cardiovascular function in HIV spectrum disease: early indications of cardiac pathophysiology.

Authors:  K A Brownley; J R Milanovich; S J Motivala; N Schneiderman; L Fillion; J A Graves; N G Klimas; M A Fletcher; B E Hurwitz
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

Review 2.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

3.  Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system.

Authors:  Denis G Kay; Ping Yue; Zaher Hanna; Serge Jothy; Etienne Tremblay; Paul Jolicoeur
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

4.  Cardiac Dysfunction in HIV-1 Transgenic Mouse: Role of Stress and BAG3.

Authors:  Joseph Y Cheung; Jennifer Gordon; JuFang Wang; Jianliang Song; Xue-Qian Zhang; Douglas G Tilley; Erhe Gao; Walter J Koch; Joseph Rabinowitz; Paul E Klotman; Kamel Khalili; Arthur M Feldman
Journal:  Clin Transl Sci       Date:  2015-08-24       Impact factor: 4.689

Review 5.  Prevalence of cardiometabolic syndrome in HIV-infected persons: a systematic review.

Authors:  Minyahil Woldu; Omary Minzi; Ephrem Engidawork
Journal:  J Diabetes Metab Disord       Date:  2020-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.